Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Core binding factor acute myeloid leukemia (AML) comprises two subtypes with distinct cytogenetic abnormalities of either t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). Since long-term response to chemotherapy in these leukemias is relatively good, allogeneic hematopoietic stem cell transpla...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kazimierz Halaburda, Myriam Labopin, Audrey Mailhol, Gerard Socié, Charles Craddock, Mahmoud Aljurf, Dietrich Beelen, Jan J. Cornelissen, Jean-Henri Bourhis, Hélène Labussière-Wallet, Didier Blaise, Tobias Gedde-Dahl, Maria Gilleece, Ibrahim Yakoub-Agha, Ghulam Mufti, Jordi Esteve, Mohamad Mohty, Arnon Nagler
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ferrata Storti Foundation 2020-06-01
Edice:	Haematologica
On-line přístup:	https://haematologica.org/article/view/9449
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!